Cancer immunotherapy: predict outcomes better with combination biomarkers, Online lectures, 水曜日, 11. 9月 2019

Immunotherapies are amazing drugs against cancer. However, they still fail for too many patients. In this series of lectures, I present IMPRES and TIDE, two of the best predictors of cancer immunotherapy outcomes. I also show an easy way to combine them and improve their predictions, using a combination biomarker. Finally, I make suggestions of practical ways to contribute to research on this topic.
Speaker: Mostapha Benhenda, bioinformatician at Melwy.com
You will receive the link to the lectures by registering to this event.

Cancer immunotherapy: predict outcomes better with combination biomarkers

もっと面白いイベントを探します
自分のFacebookの味に基づいて、イベントの推奨を取得します。今それを入手!私は私のために適したイベントを表示今はやめろ